Spring 2019
|
BUMCP Amphitheater
Banner University Medical Center 1111 East McDowell Road Phoenix, AZ |
ACCME/AMA PRA Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Arizona Medical Association (ArMA) through the joint providership of the MORE Foundation and the Arizona Society of Pathologists. MORE Foundation is accredited by ArMA to provide continuing medical education for physicians. MORE Foundation designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. |
The AZ Society of Pathologists selected these topics based on a survey of the membership to determine educational needs and interests received from evaluations on past meetings. The goal of the planning committee is to include different topics on a rotating basis, so our members are exposed to the latest innovations in a timely manner.
Rajal B. Shah, MD from the Cleveland Clinic will provide two talks covering updates on prostate cancer and prostate cancer diagnosis in core needle biopsy, along with an update on what is new in the WHO classification and 8th Edition of AJCC Staging Manual for bladder cancer. In addition, Ernest Jimenez, laboratory operations manager at Pharos Diagnostics in Tucson, will provide two talks on pain management and urine drug testing for opioids and other related drugs. Richard Eisen, MD will provide an update on PD-L1 and then join Xia Li, PhD for a presentation on tumor profiling by NGS analysis.
Rajal B. Shah, MD from the Cleveland Clinic will provide two talks covering updates on prostate cancer and prostate cancer diagnosis in core needle biopsy, along with an update on what is new in the WHO classification and 8th Edition of AJCC Staging Manual for bladder cancer. In addition, Ernest Jimenez, laboratory operations manager at Pharos Diagnostics in Tucson, will provide two talks on pain management and urine drug testing for opioids and other related drugs. Richard Eisen, MD will provide an update on PD-L1 and then join Xia Li, PhD for a presentation on tumor profiling by NGS analysis.
Schedule
|
8:25-8:30 am Welcome/Introductions
Chris Stasik, DO, President Anil Prasad, Program Chair 8:30-9:15 am Pain Management Drug Testing: A Laboratory Perspective Ernest Jimenez, MT 9:15-10:00 am Update on PD-L1: The What, Why and How in a Growing and Complicated Testing Environment Richard Eisen, MD 10:00-10:30 am Break/Visit Exhibitors 10:30-11:15 am 3-Step Approach to Prostate Cancer Diagnosis in Core Needle Biopsy Rajal B. Shah, MD 11:15-12:00 pm Update on Prostate Cancer: New Developments in Diagnosis, Grading, Staging and Reporting Rajal B. Shah, MD 12:15-1:15 pm Lunch – APS Business Meeting |
1:15 -2:00 pm Update on Bladder Cancer: What is New in the 2016
WHO Classification and 8th Edition of AJCC Staging Manual Rajal B. Shah, MD 2:00-2:15 pm Break/Visit Exhibitors 2:15-3:00 pm Novel Drugs of Abuse: Updates to the Current Rave Ernest Jimenez, MT 3:00-3:30 pm Resident Talk 3:30-4:30 pm Tumor Profiling by NGS Analysis: A Case Based Update Richard Eisen, MD Xia Li, PhD 4:30–5:00 pm Closing Comments/Q & A |
Presentations
|
Rajal Shah, MD
|
Richard Eisen, MD and Xia Li, PhD
|
|
| ||||
|
| ||||
| shah_bladdercancerupdate.pdf |
Ernest Jiminez
|
| ||||||||